We are live on ! Find out more
Brighton Jones

Brighton Jones Portfolio holdings

AUM $5.73B Turnover 18.7%
1-Year Est. Return 24.99%
 

Brighton Jones is a wealth management firm built around what it calls the Personal CFO approach, in which one team plans across a client's whole balance sheet, assets and debts alike. Its founders, Charles Brighton and Jon Jones, launched it in 2000 and are still its principal owners. Portfolios are customized for each client and draw on academic research in traditional and behavioral finance. The firm also runs OpenPlan for individual financial planning and retirement plan advice, Lenora Capital for private investments, and a trust company chartered in South Dakota.

This Fund
S&P 500
This Quarter Est. Return
+5.16%
1 Year Est. Return
+24.99%
3 Year Est. Return
+114.24%
5 Year Est. Return
+128%
10 Year Est. Return
+519.75%
AUM
$5.73B
AUM Growth
+$348M
Cap. Flow
+$184M
Cap. Flow %
3.21%
Top 10 Hldgs %
42.27%
Holding
1,551
New
126
Increased
711
Reduced
517
Closed
164
Avg Time Held Equity + Options
0.7 years
Top 10 Avg Time Held Equity + Options
5.2 years
Top 20 Avg Time Held Equity + Options
4.8 years
Avg Time Held Equity only
0.7 years
Top 10 Avg Time Held Equity only
5.2 years
Top 20 Avg Time Held Equity only
4.8 years

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$32.8M
2
SPCX icon
SpaceX
SPCX
+$14.8M
3
DCOR icon
Dimensional US Core Equity 1 ETF
DCOR
+$13.8M
4
AAPL icon
Apple
AAPL
+$11.7M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$8.57M

Top Sells

Rank Stock Value
1
LII icon
Lennox International
LII
+$13.1M
2
PCG icon
PG&E
PCG
+$4.34M
3
WMT icon
Walmart
WMT
+$3.93M
4
DELL icon
Dell
DELL
+$3.07M
5
CHWY icon
Chewy
CHWY
+$3.06M

Sector Composition

Rank Sector Weight
1 Miscellaneous 31.74%
2 Technology 24.05%
3 Consumer Discretionary 21%
4 Financials 5.26%
5 Healthcare 4.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
TDUP icon
1376
ThredUp
TDUP
$208M
$22.8K ﹤0.01%
10,759
-25,962
-71% -$107K
2026 Q2
1 quarter
ALLO icon
1377
Allogene Therapeutics
ALLO
$276M
$21.4K ﹤0.01%
13,357
-19,645
-60% -$37.4K
2026 Q1
2 quarters
ELME icon
1378
DELISTED
Elme Communities
ELME
$20.9K ﹤0.01%
11,998
-2,089
-15% -$3.39K
2026 Q1
2 quarters
CRDF icon
1379
Cardiff Oncology
CRDF
$72M
$20.3K ﹤0.01%
16,741
-3,712
-18% -$3.98K
2026 Q1
2 quarters
WIT icon
1380
Wipro
WIT
$21B
$19.8K ﹤0.01%
12,003
-4,440
-27% -$8.15K
2026 Q2
1 quarter
REI icon
1381
Ring Energy
REI
$302M
$14K ﹤0.01%
+10,693
New +$14.3K
2026 Q3
0 quarters
DCGO icon
1382
DocGo
DCGO
$18.9M
$5.08K ﹤0.01%
12,692
-12,610
-50% -$6.45K
2026 Q1
2 quarters
PROP icon
1383
Prairie Operating
PROP
$49.1M
$4.37K ﹤0.01%
10,617
-14,253
-57% -$8.93K
2026 Q2
1 quarter
ARAY icon
1384
Accuray
ARAY
$8.34M
$3.86K ﹤0.01%
358
-333
-48% -$3.49K
2026 Q2
1 quarter
ACM icon
1385
Aecom
ACM
$9.2B
– –
-5,065
Closed -$354K –
AIP icon
1386
Arteris
AIP
$931M
– –
-6,655
Closed -$323K –
AKBA icon
1387
Akebia Therapeutics
AKBA
$128M
– –
-19,650
Closed -$22.4K –
ALDX icon
1388
Aldeyra Therapeutics
ALDX
$39.8M
– –
-16,144
Closed -$34.4K –
ALGM icon
1389
Allegro MicroSystems
ALGM
$5.34B
– –
-4,775
Closed -$332K –
ALIT icon
1390
Alight
ALIT
$349M
– –
-11,367
Closed -$127K –
ALT icon
1391
Altimmune
ALT
$304M
– –
-12,596
Closed -$38.3K –
AMBA icon
1392
Ambarella
AMBA
$2.5B
– –
-2,568
Closed -$220K –
APG icon
1393
APi Group
APG
$18.3B
– –
-5,018
Closed -$213K –
ARDX icon
1394
Ardelyx
ARDX
$782M
– –
-14,301
Closed -$72.9K –
AROC icon
1395
Archrock
AROC
$4.77B
– –
-5,539
Closed -$225K –
AVA icon
1396
Avista
AVA
$3.46B
– –
-7,438
Closed -$304K –
AVB icon
1397
DELISTED
AvalonBay Communities
AVB
– –
-1,602
Closed -$302K –
AXTA icon
1398
Axalta
AXTA
$7.77B
– –
-6,819
Closed -$233K –
AXSM icon
1399
Axsome Therapeutics
AXSM
$7.21B
– –
-858
Closed -$210K –
BCRX icon
1400
BioCryst Pharmaceuticals
BCRX
$1.96B
– –
-16,926
Closed -$169K –

Similar funds

Brighton Jones's Q3 2026 Portfolio in Review

As of Q3 2026, Brighton Jones held 1,551 positions worth $5.73B, up 6.5% from $5.38B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Brighton Jones deployed $184M of net new capital in Q3 2026, opening 126 new positions and adding to 711 existing holdings. Its largest new stake was Cerebras Systems: 13,609 shares worth $2.42M.

By sector, the portfolio is most concentrated in Miscellaneous at 32% of assets, down from 32% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Lennox International, an estimated $13.1M trimmed.

  • Brighton Jones's largest Q3 2026 buy was Cerebras Systems: 13,609 shares worth $2.42M.
  • Brighton Jones added most to NVIDIA in Q3 2026, an estimated $32.8M increase.
  • Brighton Jones's biggest Q3 2026 reduction was Lennox International, cutting an estimated $13.1M.
  • Brighton Jones fully exited Burlington in Q3 2026, selling an estimated $1.6M.
  • Brighton Jones's ten largest holdings make up 42% of its $5.73B portfolio in Q3 2026.
  • Brighton Jones opened 126 new positions and closed 164 in Q3 2026.
  • Brighton Jones's portfolio value rose 6.5% quarter-over-quarter to $5.73B.

Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.